HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Keppel’s Rebirth As A Global Asset Manager – 2H25 & FY25

The $14.5 Billion Pivot: How a Legacy Giant is Quietly Powering the AI Gold...
SGX-LISTED COMPANIES

5 Surprising Ways CapitaLand China Trust Is Reimagining The “New China” Economy In FY2025

Introduction The prevailing narrative surrounding China’s real estate sector remains one of caution, characterized by...
SGX-LISTED COMPANIES

Why Keppel REIT Just Went All In On Australian Retail In FY2025

The 47.9% Leverage Illusion: Why Keppel REIT’s Sydney Pivot is a Calculated Power Move Introduction:...
SGX-LISTED COMPANIES

ESR-REIT’s High-Spec FY2025 Pivot Pays Off

The 10-for-1 Shift: 5 Surprising Truths Hidden in ESR-REIT’s FY2025 Results The global trade landscape...
SGX-LISTED COMPANIES

Inside Digital Core REIT’s US$1.8 Billion Global Pivot – FY2025

Consolidation and Currency Hedges Every time you stream high-definition content, execute a high-frequency trade, or...
SGX-LISTED COMPANIES

Why Lion Asiapac’s S$6.4 Million Loss Masks A Cash-Rich Pivot – Q2 & 1H2026

The Paper Deficit For the undisciplined investor, the half-year results from Lion Asiapac Limited for...
SGX-LISTED COMPANIES

Keppel Infrastructure Trust Trades Oil Storage For Subsea Cables In FY2025

The S$9 Billion Lifeblood: How Infrastructure is Quietly Powering the AI and Energy Revolution Infrastructure...
SGX-LISTED COMPANIES

Why Maruwa’s Q3 FY2025 Profit Dropped Despite AI Boom

The Silicon & Ceramic Pulse: 5 Surprising Realities from Maruwa’s Q3 Results Introduction: The Invisible...
SGX-LISTED COMPANIES

Pickleball, Tech Hubs & The Great Dividend Comeback – KORE US REIT FY2025

The New Geography of the American Office For the better part of three years, the...
SGX-LISTED COMPANIES

How ASTI Holdings Flipped The Script In Q3 2025

The $1.3 Million Turnaround Introduction: A Tale of Resilience and Red Ink For stakeholders of ASTI...
SGX-LISTED COMPANIES

CapitaLand India Trust Pivots From Offices To Data Centers In FY2025

The Data Infrastructure Gambit: Inside CapitaLand India Trust’s Record Distribution Surge In a global economy...
SGX-LISTED COMPANIES

Why Keppel DC REIT’s FY2025 Signals The Rise Of Infrastructure Sovereignty

The Digital Backbone: Why Your Digital Footprint is the New Real Estate Gold When you...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...